YORINOBU MAEDA | Drug Delivery Systems | Pharmaceutical Advancement Award

YORINOBU MAEDA | Drug Delivery Systems | Pharmaceutical Advancement Award

Prof Dr YORINOBU MAEDA, Fukuyama university, Japan

Prof. Dr. Yorinobu Maeda, Ph.D. (Hiroshima University, 1990), is a renowned expert in drug safety, pharmacokinetics, and infection control. As a professor at Fukuyama University and Drug Safety Director, he has advanced renal function-based dosing and prescription optimization. His contributions have earned him multiple awards, including Best Paper Awards (2001, 2005) and an Academic Contribution Award (2014) from the Japanese Society of Pharmaceutical Health Care and Sciences. With a strong academic and clinical impact, Dr. Maeda is a leading figure in pharmaceutical advancements, ensuring better patient safety and treatment efficacy. πŸ…πŸ”¬

Publication Profile

scopus

Educational and Professional Background

Prof. Dr. Yorinobu Maeda has a distinguished background in pharmaceutical sciences, earning his Ph.D. from Hiroshima University in 1990 πŸŽ“. His expertise spans infection control, hospital pharmacy specialization, and drug safety leadership, reflecting his dedication to pharmaceutical advancements πŸ’Š. With leadership roles in major hospitals πŸ₯ and an esteemed position as a professor at Fukuyama University πŸŽ“, he has made significant academic and practical contributions to the field. His work continues to shape the future of pharmacy, ensuring patient safety and advancing healthcare practices for better medical outcomes πŸŒπŸ”¬.

Contributions to Pharmaceutical Sciences

Prof. Dr. Yorinobu Maeda has made significant contributions to pharmaceutical sciences, particularly in drug safety, pharmacokinetics, and dosage optimization πŸ’ŠπŸ”¬. His research focuses on infection control 🦠, renal function-based dosing πŸ₯, and improving prescription practices, directly enhancing patient safety and treatment efficacy πŸ‘¨β€βš•οΈβœ…. As a Drug Safety Director, he plays a crucial role in advancing pharmaceutical practices, ensuring medications are used effectively and safely. His dedication to optimizing drug therapy and refining medical protocols continues to have a lasting impact on healthcare, improving outcomes for patients worldwide πŸŒπŸ’‰.

Awards and Recognitions

Prof. Dr. Yorinobu Maeda has made remarkable contributions to the field of pharmaceutical healthcare, earning numerous prestigious accolades from the Japanese Society of Pharmaceutical Health Care and Sciences. His achievements include the Best Paper Awards in 2001 and 2005 πŸ†, as well as the esteemed Academic Contribution Award in 2014 πŸŽ“. These honors highlight his dedication to advancing research and implementing pharmacokinetic principles to enhance patient safety and care 🩺. Dr. Maeda’s work stands as a testament to his unwavering commitment to improving healthcare standards and fostering innovation in pharmaceutical sciences. 🌟

Research Focus

Professor Dr. Yorinobu Maeda is an eminent researcher specializing in pharmaceutical sciences, with a primary focus on drug bioavailability, prodrug development, and therapeutic drug monitoring. His work spans areas such as drug absorption, small intestinal bacterial overgrowth diagnosis, and managing adverse drug reactions. Notable research includes the impact of metal ions on drug efficacy and innovative prodrug strategies. Through collaborative studies, he contributes to optimizing drug delivery systems and clinical pharmacotherapy, enhancing patient safety and treatment outcomes. πŸ§ͺπŸ’Š

Publication Top Notes

5-Aminosalicylic Acid Distribution into the Intestinal Membrane Along the Gastrointestinal Tract After Oral Administration in Rats

Development and Evaluation of EDTA-Treated Rabbits for Bioavailability Study of Chelating Drugs Using Levofloxacin, Ciprofloxacin, Hemiacetal Ester Prodrugs, and Tetracycline

Diagnosis by Microbial Culture, Breath Tests and Urinary Excretion Tests, and Treatments of Small Intestinal Bacterial Overgrowth

Ester Prodrugs of Levofloxacin to Prevent Chelate Formation in Presence of Aluminium Ion

Study on the method to avoid infusion‑site adverse events following chemotherapeutic treatment with epirubicin and fosaprepitant using immortalized human umbilical vein endothelial cells

Effect of aluminium ion on bioavailability of levofloxacin following oral administration of cilexetil ester of levofloxacin as prodrug in rats

 

Prof Dr. THAWATCHAI PHAECHAMUD| Drug Delivery Systems | Best Researcher Award-1299

Prof Dr. THAWATCHAI PHAECHAMUD, Drug Delivery Systems ,Best Researcher Award

Prof Dr. THAWATCHAI PHAECHAMUD atSilpakorn University,Thailand

PROFILEΒ Β 

Google scholarΒ 

Scopus

Orcid

Early Academic Pursuits πŸŽ“

Thawatchai Phaechamud, Mr., embarked on his academic journey at the Faculty of Pharmacy, Silpakorn University, Thailand, where he earned his Bachelor of Pharmacy (B.Pharm) degree in 1991. Demonstrating a strong interest in pharmaceutical sciences from an early stage, he advanced his studies at the Faculty of Pharmaceutical Sciences, Chulalongkorn University. There, he completed his Master of Science (M.Sc.) in Manufacturing Pharmacy in 1995, with a thesis focused on the “Effect of variables in chitosan film on propranolol hydrochloride coated tablets.” His academic journey culminated in a Ph.D. in Pharmaceutics from the same institution in 1999. His doctoral thesis, titled β€œFilm-coating of chitosan onto propranolol hydrochloride tablet: Approach to fast and extended drug release,” laid the foundation for his future contributions to the field of pharmaceutics, particularly in drug delivery systems.

Professional Endeavors πŸ§‘β€πŸ«

Mr. Phaechamud began his professional career as a Lecturer at the Faculty of Pharmacy, Silpakorn University, Nakhon Pathom, from 1991 to 1993. During this period, he honed his teaching skills and laid the groundwork for a lifelong commitment to academia. From 1994 to 1996, he served as a research student at the Faculty of Pharmaceutical Sciences, Chulalongkorn University, further deepening his research capabilities. His academic prowess earned him a position as a Visiting Scientist at the Department of Pharmaceutics, Toyama Medical & Pharmaceutical University in Japan from November 1997 to January 1998.

Upon completing his Ph.D., Mr. Phaechamud returned to Silpakorn University, where he served as an Assistant Professor from 1999 to 2003 in the Department of Pharmaceutical Technology. His dedication to teaching and research led to his promotion to Associate Professor in 2004, a position he has held ever since. His roles have expanded over the years, including serving as the Head of the Department of Pharmaceutical Technology from 2008 to 2009 and Chairman of the Pharmaceutical Engineering Doctoral Program from 2017 to 2018. Since 2018, Mr. Phaechamud has held the esteemed title of Professor in the Department of Industrial Pharmacy, Faculty of Pharmacy at Silpakorn University.

Contributions and Research Focus πŸ”¬

Mr. Phaechamud’s research interests are diverse, focusing on various aspects of pharmaceutical sciences. His work primarily revolves around controlled drug delivery systems, in situ forming gels, matrix film and tablet characterizations, herbal preparation and development, pharmaceutical film coating, and pharmaceutical excipient characterization. He has made significant contributions to the development of controlled drug delivery systems, a field that aims to enhance the efficacy and safety of medications by controlling the rate, time, and place of drug release.

His expertise in polymeric film characterization and pharmaceutical excipient characterization has been instrumental in advancing the understanding of drug delivery mechanisms. His work on in situ forming gels and matrix films has paved the way for innovative drug delivery solutions, particularly in the treatment of chronic conditions where sustained drug release is crucial.

Accolades and Recognition πŸ†

Throughout his illustrious career, Mr. Phaechamud has received numerous accolades and recognition for his contributions to pharmaceutical sciences. In June 2006, he was honored as a TRF Research Scholar by The Thailand Research Fund, a prestigious recognition of his research excellence. His leadership in the β€œDevelopment of standard extract of SC for pharmaceutical and cosmetic applications” research program at Silpakorn University in 2008-2009 further solidified his reputation as a leading researcher in his field.

His publications in high-impact journals reflect the quality and impact of his research. Notable publications include works in the International Journal of Biological Macromolecules, Polymers, AAPS PharmSciTech, and Pharmaceutics, where his research on topics such as transdermal and periodontal pocket drug delivery systems, in situ gels, and solvent-removal zein-based in situ gels has garnered significant attention.

Impact and Influence 🌍

Mr. Phaechamud’s research has had a profound impact on the field of pharmaceutics, particularly in the area of drug delivery systems. His work on controlled drug delivery systems and in situ forming gels has influenced the development of new therapeutic approaches that improve patient outcomes by ensuring more effective and targeted drug delivery.

His influence extends beyond research; as an educator, he has mentored countless students, many of whom have gone on to become leaders in the pharmaceutical industry and academia. His teachings on modified release solid dosage forms, controlled drug delivery systems, and polymer degradation have been instrumental in shaping the next generation of pharmaceutical scientists.

Legacy and Future Contributions 🌟

Mr. Phaechamud’s legacy is one of innovation, dedication, and excellence in the field of pharmaceutical sciences. His work has not only advanced the understanding of drug delivery mechanisms but also paved the way for new therapeutic solutions that have the potential to improve the lives of millions of patients worldwide.

As he continues his work at Silpakorn University, Mr. Phaechamud is

πŸŽ“PublicationΒ 

Moist heat treatment on physicochemical change of chitosan salt films

  • AuthorsΒ  Β :Garnpimol C Ritthidej, Thawatchai Phaechamud, Tamotsu Koizumi
  • JournalΒ  Β  :International journal of pharmaceutics
  • YearΒ  Β  Β  Β  Β :2002

Gentamicin sulfate-loaded porous natural rubber films for wound dressing

    • Authors :Thawatchai Phaechamud, Pongsathorn Issarayungyuen, Wiwat Pichayakorn
    • JournalΒ  Β :International journal of biological macromolecules
    • YearΒ  Β  Β  Β : 2016

Sustained-release from layered matrix system comprising chitosan and xanthan gum

  • AuthorsΒ  :Thawatchai Phaechamud, Garnpimol C Ritthidej
  • JournalΒ  Β  :Drug development and industrial pharmacy
  • YearΒ  Β  Β  Β  Β :Β  2007

The study of antioxidant capacity in various parts of Areca catechu L.

  • AuthorsΒ  :Penpun Wetwitayaklung, Thawatchai Phaechamud, Chutima Limmatvapirat, Sindhchai Keokitichai
  • JournalΒ  Β :Naresuan University Journal: Science and Technology (NUJST)
  • YearΒ  Β  Β  Β  :Β  Β 2006

Antibacterial activity and drug release of chitosan sponge containing doxycycline hyclate

  • AuthorsΒ  :Thawatchai Phaechamud, Juree Charoenteeraboon
  • JournalΒ  Β :Aaps PharmSciTech
  • YearΒ  Β  Β  Β  :Β  2008

Prof Dr.Dinesh Mishra, Drug Delivery Systems,Best Researcher Award

Prof Dr.Dinesh Mishra, Drug Delivery Systems ,Best Researcher Award

Prof Dr.Dinesh Mishra, atDepartment of Pharmacy, Guru Ghasidas Vishwavidyalaya (A Central University), Bilaspur,India

Author Profile

 

Educational Background

Dr. Dinesh Kumar Mishra holds a Ph.D. in Pharmaceutics from Dr. H. S. Gour University, Sagar, where he studied under the supervision of Prof. N. K. Jain. He completed his M. Pharm. in Pharmaceutics from the same institution, achieving a merit-holder distinction. Dr. Mishra’s academic journey began with a B. Pharm. degree from Dr. H. S. Gour University, followed by secondary education credentials from the M.P. Board.

Professional Experience

Dr. Mishra has an extensive teaching and administrative career spanning over two decades. He is currently a Professor at Guru Ghasidas Vishwavidyalaya, a position he has held since July 2023. Prior to this, he served as Principal and Professor at Indore Institute of Pharmacy and held various academic roles at NMIMS, IPS Academy, SLT Institute of Pharmaceutical Sciences, Mahakal Institute of Pharmaceutical Studies, Shri Ram Institute of Technology, and AND College of Pharmacy.

Teaching and Administrative Roles

  • UG Teaching Experience: 21 years
  • PG Teaching Experience: 19 years
  • Principal at Indore Institute of Pharmacy: 4 years
  • HOD, M. Pharm (Pharmaceutics): 8 years
  • Exam Center Superintendent, IPS Academy College of Pharmacy: 2 years
  • Academic In-charge, IPS Academy College of Pharmacy: 2 years

Research Credentials

Dr. Mishra’s research credentials are noteworthy, with a cumulative impact factor of 245, 4700 citations, an h-index of 38, and an i-10 index of 58. He has guided numerous students at both undergraduate and postgraduate levels, as well as Ph.D. candidates.

Ph.D. Research Supervision

  1. Dr. Shriprakash Mishra – Development of mucoadhesive microsphere for the treatment of peptic ulcer (Awarded)
  2. Mr. Pritam R. Siraskar – Formulation, characterization, and optimization of gastro retentive floating microspheres using quality by design approach (Awarded)
  3. Mr. Devkant Sharma – Formulation, evaluation, and optimization of nanotechnology-based drug delivery system for psoriasis treatment (Awarded)
  4. Ms. Nayany Sharma – Development of silver nanoparticles-based topical gel containing herbal actives for wound healing
  5. Ms. Neha Kamalpuria – Formulation, optimization, and evaluation of lipid-based nanocarrier gel for topical drug delivery
  6. Ms. Triveni – Design, optimization, and characterization of antifungal drug loaded transferosome based hydrogels for the management of foot dermatophytosis

Honors and Awards

Dr. Mishra has received numerous accolades for his contributions to pharmaceutical sciences, including being listed among the world’s top 2% scientists by Elsevier in 2022 and 2023. He has also received several prestigious awards such as the Prof. M. L. Schroff Pharma Recognition Award, the Outstanding Scientist Award, the Best Scientist Award, and the Eminent Principal Award.

Collaborations and Grants

Dr. Mishra has collaborated with notable institutions such as NIPER Ahmedabad, NIREH ICMR Bhopal, and Central University of Rajasthan. He has successfully secured research grants from various bodies, including MPCST, AICTE, NMIMS University, and UGC-BSR.

Professional Memberships
He is a life member of several esteemed professional bodies including APTI, IPA, ISCA, IPGA, APP, SPER, and ISSRF.

πŸŽ“Publication Top Noted:

Paper Title :Full factorial design-based development and characterization of ciclopirox olamine loaded transferosomes: An efficient approach for the management of Athlete’s foot

  • Authors:Triveni, Upendra Nagaich, Dinesh Kumar Mishra, Neha Jain
  • Journal:Journal of Drug Delivery Science and Technology
  • Year: 2024
Paper Title :New emerging technologies for genetic toxicity testing
    • Authors: Kuldeep Vinchurkar, Jitendra Sainy, Masheer Ahmed Khan, Sheetal Mane, Dinesh K. Mishra, Pankaj Dixit
    • Journal:Pharmacokinetics and Toxicokinetic Considerations
    • Year: 2022
Paper Title :Features and Facts of a Gastroretentive Drug Delivery System-A Review
  • Authors:Kuldeep Vinchurkar, Jitendra Sainy, Masheer Ahmed Khan, Sheetal Mane, Dinesh K. Mishra, Pankaj Dixit
  • Journal:Turkish Journal of Pharmaceutical Sciences
  • Year:2022
Paper Title :3D Printing for Drug Delivery and its Pharmaceutical Applications – Recent Findings and Challenges
  • Authors: Kuldeep Vinchurkar, Jitendra Sainy, Masheer Ahmed Khan, Sheetal Mane, Dinesh K. Mishra, Pankaj Dixit
  • Journal: International Journal of Pharmaceutical Sciences and Nanotechnology
  • Year: 2022

Paper Title :Recent update of toxicity aspects of nanoparticulate systems for drug delivery

  • Authors: Patnaik, S., Gorain, B., Padhi, S., Choudhury, H., Gabr, G.A., Md, S., Kumar Mishra, D., Kesharwani, P.
  • Journal:European Journal of Pharmaceutics and Biopharmaceutics
  • Year:2021